Modulation of Fluorouracil Cytotoxicity by Interferon-α and -γ

Abstract

Because interferons (IFN)-α and -γ individually have increased fluorouracil (FUra) cytotoxicity in several in vitromodels, we studied the effects of FUra combined with IFN-α + γ in HT29 colon cancer cells. A 96-hr exposure to IFN-α (500 units/ml) plus IFN-γ (10 units/ml) and a 72-hr exposure to 0.25–1 μm FUra (hr 24–96) inhibited cell growth and colony formation in an additive or more-than-additive fashion. When cells were exposed to IFN-α + γ and FUra, free FdUMP levels became detectable, whereas [3H]FUra-RNA incorporation decreased. Exposure to IFN-α + γ, FUra, or the combination decreased dTTP pools to 58%, 43%, and 17% of control, respectively. A marked increase in the dATP to dTTP ratio was seen with FUra with or without IFN-α + γ. Thymidylate synthase catalytic activity was reduced to 28% and 24% of control with FUra with or without IFN-α + γ, suggesting that the enhanced dTTP depletion must be due to another mechanism. FUra-mediated thymidylate synthase inhibition was accompanied by a 124-fold increase in total deoxyuridylate immunoreactivity and a 31-fold increase in dUTP pools, but the addition of IFN-α + γ attenuated the accumulation. Treatment with IFN-α + γ and FUra individually interfered with nascent DNA chain elongation, whereas the three-drug combination produced the most striking effects. IFN-α + γ plus FUra produced the greatest amount of single-strand breaks in nascent DNA and dramatically decreased net DNA synthesis. IFN-α + γ with or without FUra produced double-strand breaks in parental DNA. These results suggest that dTTP depletion, dATP/dTTP imbalance, pronounced inhibition of DNA synthesis, and damage to nascent and parental DNA contribute to the enhanced cytotoxicity with the triple combination.

Footnotes

  • Send reprint requests to: Dr. Jean L. Grem, NCI-NMOB, National Naval Medical Center, Building 8, Room 5101, Bethesda, MD 20889. E-mail: jgrem{at}helix.nih.gov

  • 1 Current affiliation: Department of Radiation Oncology, University of Alexandria, Alexandria, Egypt.

  • 2 Current affiliation: Department of Medical Oncology, Free University Hospital, Amsterdam, The Netherlands.

  • This work was supported in part by a research stipend provided by the Egyptian Cultural Bureau of the Embassy of Egypt (A.-S.A.I.).

  • Abbreviations:
    IFN
    interferon
    FUra
    5-fluorouracil
    HPLC
    high performance liquid chromatography
    FdUMP
    5-fluoro-2′-deoxyuridine-5′-monophosphate
    TS
    thymidylate synthase
    TCA
    trichloroacetic acid
    FI
    fractional inhibition
    • Received May 28, 1997.
    • Accepted October 15, 1997.
« Previous | Next Article »Table of Contents